Skip to main content
POLAREAN IMAGING PLC logo

POLAREAN IMAGING PLC — Investor Relations & Filings

Ticker · POLX ISIN · GB00BF3DT583 LEI · 213800DGR2BHXJ36OL37 IL Manufacturing
Filings indexed 313 across all filing types
Latest filing 2025-01-28 Regulatory Filings
Country GB United Kingdom
Listing IL POLX

About POLAREAN IMAGING PLC

https://polarean.com

Polarean Imaging PLC is a medical technology company that develops and commercializes solutions for pulmonary imaging. The company's core focus is its drug-device combination product utilizing hyperpolarized Xenon-129 gas Magnetic Resonance Imaging (XeMRI). This non-invasive, radiation-free technique provides a direct, functional assessment of lung ventilation in a single breath-hold. Polarean developed XENOVIEW™ (xenon Xe 129 hyperpolarized), the first and only hyperpolarized MRI contrast agent approved by the U.S. FDA for evaluating lung ventilation. The technology platform includes the HPX Hyperpolarizer system, specialized gas blends, and dedicated MRI coils, designed to aid in the diagnosis and management of chronic lung diseases.

Recent filings

Filing Released Lang Actions
Collaboration to Advance Lung Imaging Innovation
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 8630U' and concludes with information about RNS, the news service of the London Stock Exchange, stating it is approved by the Financial Conduct Authority to act as a Primary Information Provider. The content itself is an announcement detailing a strategic collaboration between Polarean Imaging plc and SimonMed Imaging regarding the Xenon MRI platform. This is a general corporate announcement released via the regulatory news service, not a formal periodic report (like 10-K or IR) or a specific document like an AGM presentation or proxy statement. Since it is a general regulatory announcement distributed through the official news service (RNS) and doesn't fit the more specific categories (like ER, CAP, or DIV), the most appropriate classification is the general Regulatory Filings category.
2025-01-28 English
Block Listing Six Monthly Return
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a 'Block Listing Six Monthly Return' for the 'Polarean Share Option Plan'. It details the balance of unallotted securities under a scheme over a specific period (27 July 2024 to 24 January 2025) and concludes with standard RNS distribution information. This type of filing, which reports on the status of securities under an admission arrangement (like a block listing return), is a routine regulatory disclosure. Since it is not a major financial report (10-K, IR, ER) or a specific corporate action announcement (DIV, SHA, DIRS), and it is a formal regulatory notification distributed via RNS, it best fits the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements not covered by more specific codes.
2025-01-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 7392P' and contains the standard footer indicating it is provided by RNS, the news service of the London Stock Exchange. The content details a 'TR-1: Standard form for notification of major holdings' regarding an acquisition of voting rights by Amati Global Investors Limited, crossing a threshold. This type of mandatory disclosure to the market, especially when originating from RNS, falls under general regulatory announcements. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise fit, as TR-1 forms are the standard mechanism for reporting changes in significant share ownership.
2024-12-11 English
FDA clears Chest Coil in GE HealthCare MRI Systems
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 0374N' and is dated '21 November 2024'. It announces a specific corporate event: 'FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems'. The text is structured like a press release or regulatory news announcement, concluding with contact information and a footer explicitly stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement that does not fit the specific categories like 10-K, ER, or IR. Since it is a general regulatory news service announcement, the most appropriate classification is Regulatory Filings (RNS), as it is not a specific report type like an Earnings Release (ER) or an Interim Report (IR), nor is it a proxy statement (DEF 14A) or a management discussion (MDA).
2024-11-21 English
Virtual investor day
Report Publication Announcement Classification · 99% confidence The document is a formal announcement disseminated via RNS (RNS Number : 4849F) from Polarean Imaging PLC. The core content announces that the company will be hosting a 'Virtual Investor Day' on a future date (October 9, 2024), detailing the agenda, speakers, and registration link. This is not a full financial report (like 10-K or IR), nor is it a specific regulatory filing like a Director's Dealing or a Dividend Notice. It is an announcement about an upcoming investor event, which falls under general corporate communications. Since it is a formal announcement distributed through the RNS system, and it doesn't fit the specific categories like AGM-R (which is for materials *from* the AGM), ER, or IP (which is a presentation document), the most appropriate classification is the general regulatory announcement category, RNS, as it is a standard regulatory news service release.
2024-09-25 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half-year Report' for Polarean Imaging plc for the period ended 30 June 2024. It contains detailed financial highlights, revenue figures, operating expenses, and a CEO statement discussing business performance and outlook. Since it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2024
2024-09-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.